3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Dendritic Cell Sarcoma, Interdigitating
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Burkitt Lymphoma
39
Lymphoma, Follicular
37
Leukemia, Lymphocytic, Chronic, B-Cell
37
Lymphoma, Mantle-Cell
36
Lymphoma, B-Cell, Marginal Zone
35
Multiple Myeloma
34
Lymphoma, Non-Hodgkin
33
Lymphoma, Large-Cell, Immunoblastic
33
Leukemia, Myeloid, Acute
33
Hodgkin Disease
33
Lymphoma, Large B-Cell, Diffuse
32
Recurrence
30
Myelodysplastic Syndromes
29
Leukemia
28
Myeloproliferative Disorders
27
Leukemia, Myeloid, Chronic-Phase
27
Congenital Abnormalities
27
Lymphoma
26
Leukemia, Myeloid, Accelerated Phase
24
Lymphoma, Large-Cell, Anaplastic
21
Waldenstrom Macroglobulinemia
20
Sezary Syndrome
20
Mycosis Fungoides
20
Leukemia, Myelomonocytic, Chronic
20
Lymphoma, T-Cell, Cutaneous
19
Leukemia, Myelomonocytic, Juvenile
19
Primary Myelofibrosis
17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
fludarabine phosphate
×
Sarcoma
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled